Efficacy and in vitro activity of gepotidacin against bacterial uropathogens, including drug-resistant phenotypes, in females with uncomplicated urinary tract infections: results from two global, pivotal, phase 3 trials (EAGLE-2 and EAGLE-3). - Scangarella-Oman NE; Butler DL; Breton J; Brown D; Kasapidis C; Millns H; Huang C; Perry CR; Sheets AJ; Dennison J; Janmohamed S (Antimicrobial agents and chemotherapy, 2025)